Grade My Investments

West Pharmaceutical Services, Inc. (WST) Stock Grade

WST · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$19.9B
P/E Ratio
40.3
Revenue Growth (YoY)
+6.3%
Net Margin
16.1%
Return on Equity
15.5%
Dividend Yield
0.3%

About West Pharmaceutical Services, Inc.'s fundamentals

West Pharmaceutical Services is a $19.9 billion healthcare company specializing in medical instruments and supplies with a net profit margin of 16.1%, indicating it converts over a sixth of its revenue into earnings. The company is growing revenue at 6.3% year-over-year while generating a 15.5% return on equity, showing solid operational efficiency and capital deployment. Trading at a P/E ratio of 40.3, the valuation reflects premium pricing relative to earnings, and the company returns minimal cash to shareholders with a 0.3% dividend yield.

Track WST free — no credit card required. Live grade + monthly AI report →